Second Quarter Results Come In On Target
While there were some line by line deviations relative to estimates, CSX came in basically as expected for the second quarter, which will likely give investors a bit more confidence about the upcoming earnings from other railroads like Norfolk Southern (NYSE:NSC), Union Pacific (NYSE:UNP), and Kansas City Southern (NYSE: KSU).
SEE: A Primer On The Railroad Sector
Top 5 Gas Stocks To Watch Right Now: Ingredion Inc (INGR)
Ingredion Incorporated (Ingredion), formerly Corn Products International, Inc., incorporated on March 27, 1997, is a global manufacturer and supplier of starch and sweetener ingredients to a range of industries, including packaged food, beverage, brewing and industrial customers. The Company's product line includes starches and sweeteners, animal feed products and edible corn oil.
The Company's starch-based products include both food-grade and industrial starches. The Company's sweetener products include glucose syrups, high maltose syrups, high fructose corn syrup (HFCS), caramel color, dextrose, polyols, maltodextrins and glucose and syrup solids. The Company's products are derived primarily from the processing of corn and other starch-based materials, such as tapioca, potato and rice.
Sweetener Products
The Company's sweetener products represented approximately 44% of the Company's net sales for the year ended December 31, 2012. Glucose syrups are fundamental ingredients used in food products, such as baked goods, snack foods, beverages, canned fruits, condiments, candy and other sweets, dairy products, ice cream, jams and jellies, prepared mixes and table syrups. Glucose syrups offer functionality in addition to sweetness to processed foods. High Maltose Syrup is special type of glucose syrup, which is primarily used as a fermentable sugar in brewing beers. High maltose syrups are also used in the production of confections, canning and some other food processing applications. The Company's high maltose syrups actually speeds the fermentation process, allowing brewers to increase capacity without adding capital.
High fructose corn syrup is used in a variety of consumer products, including soft drinks, fruit-flavored beverages, baked goods, dairy products, confections and other food and beverage products. In addition to sweetness and ease of use, high fructose corn syrup provides body,humectancy and aids in browning, freezing point and crystalliza! tion control.
Dextrose has a range of applications in the food and confection industries, in solutions for intravenous and other pharmaceutical applications, and numerous industrial applications like wallboard, biodegradable surface agents and moisture control agents. Dextrose functionality in foods, beverages and confectionary includes sweetness control; body and viscosity; acts as a bulking, drying and anti-caking agent; serves as a carrier; provides freezing point and crystallization control; and aids in fermentation. Dextrose is also a fermentation agent in the production of light beer. In pharmaceutical applications dextrose is used in IV solutions as well as an excipient suitable for direct compression in tableting.
Polyols products are sugar-free, reduced calorie sweeteners primarily derived from starch or sugar for the food, beverage, confectionery, industrial, personal and oral care, and nutritional supplement markets. In addition to sweetness, polyols inhibit crystallization; provide binding, humectancy and plasticity; add texture; extend shelf life; prevent moisture migration, and are an excipient suitable for tableting.
Maltodextrins and Glucose Syrup Solids products have a multitude of food applications, including formulations where liquid syrups cannot be used. Maltodextrins are resistant to browning, provide solubility, have a low hydroscopicity (do not retain moisture), and are ideal for their carrier/bulking properties. Glucose syrup solids have a bland flavor, remain clear in solution are easy to handle and provide bulking properties.
Starch Products
The Company's starch products represented approximately 37 % of the Company's net sales for 2012. Starches are an important component in a range of processed foods, where they are used for adhesions, clouding, dusting, expansion, fat replacement, freshness, gelling, glazing, mouth feel, stabilization and texture. Starches are also used in paper production to create a smooth s! urface fo! r printed communications and to improve strength in recycled papers. Specialty starches are used for enhanced drainage, fiber retention, oil and grease resistance, improved printability and biochemical oxygen demand control. Industrial starches are used in the production of construction materials, textiles, adhesives, pharmaceuticals and cosmetics, as well as in mining, water filtration and oil and gas drilling. Specialty starches are used for biomaterial applications including biodegradable plastics, fabric softeners and detergents, hair and skin care applications, dusting powders for surgical gloves and in the production of glass fiber and insulation.
Co-Products and others
Co-products and others accounted for 19% of the Company's net sales for 2012. Refined corn oil (from germ) is sold to packers of cooking oil and to producers of margarine, salad dressings, shortening, mayonnaise and other foods. Corn gluten feed is sold as animal feed. Corn gluten meal is sold as high protein feed for chickens, pet food and aquaculture.
The Company competes with ADM Corn Processing Division (ADM), Cargill, Inc. and Tate & Lyle Ingredients Americas, Inc.
Advisors' Opinion:- [By Jeremy Bowman]
What: Shares of Ingredion (NYSE: INGR ) were down as much as 10% today after the ingredient seller cut its full-year and current-quarter EPS forecast.
- [By Dividends4Life]
Memberships and Peers: ADM is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Dividend Champion. The company's peer group includes: Bunge Limited (BG) with a 1.6% yield, Ingredion Incorporated (INGR) with a 2.4% yield and Griffin Land & Nurseries Inc. (GRIF) with a 0.7% yield.
Hot Trucking Stocks To Invest In Right Now: Harvest Natural Resources Inc (HNR)
Harvest Natural Resources, Inc., incorporated on September 9, 1988, is a petroleum exploration and production company. The Company is engaged in the exploration, development and production of properties in geological basins with proven active hydrocarbon systems. The Company holds interest in the Bolivarian Republic of Venezuela (Venezuela). The Company's Venezuelan interests are owned through Harvest-Vinccler Dutch Holding, B.V. Through HNR Energia, B.V. (HNR Energia), the Company indirectly owns 80% of Harvest Holding and its partner, Oil & Gas Technology Consultants (Netherlands) Cooperatie U.A., indirectly owns the remaining 20% interest of Harvest Holding. Harvest Holding owns, indirectly through wholly owned subsidiaries, a 40% of Petrodelta, S.A. (Petrodelta). The Company indirectly owns a net 32% interest in Petrodelta, and Venezolana de Inversiones y Construcciones Clerico, C.A. (Vinccler) indirectly owns 8%. Corporacion Venezolana del Petroleo S.A. (CVP) owns the remaining 60% of Petrodelta. Petroleos de Venezuela S.A. (PDVS) owns 100% of CVP. Harvest Holding has a direct controlling interest in Harvest Vinccler S.C.A. (Harvest Vinccler).
As of December 31, 2012, the Company's operations were located at Venezuela, Republic of Indonesia, Republic of Gabon, Sultanate of Oman and People's Republic of China. In Venezuela operations are through the Company's Petrodelta. In Republic of Indonesia (Indonesia) the operations are mainly onshore in West Sulawesi in Indonesia through the Budong PSC. The Company owns a 64.51% interest in the Budong PSC. In Republic of Gabon (Gabon) operations are offshore of Gabon through the Dussafu PSC. The Company has a 66.667% interest in the Dussafu PSC. The Company is the operator. In Sultanate of Oman (Oman) the operations are onshore in Oman through the exploration and production sharing agreement (EPSA) Al Ghubar / Qarn Alam license (Block 64 EPSA). The Company has an 80% interest in Block 64 EPSA. The Company is the operator. In People's Republic o! f China (China) the exploration acreage is offshore of China in the South China Sea through the Wab-21 Petroleum Contract (Wab-21). The Company has a 100% interest in the WAB-21 petroleum contract. The Company is the operator.
Petrodelta is engaged the exploration, production, gathering, transportation and storage of hydrocarbons from the Petrodelta Fields. As of December 31, 2012, there were 86 oil and natural gas producing wells and seven water injection wells in the Petrodelta Fields. As of December 31, 2012, there were 15 oil producing wells and four water injection wells in the Tucupita Field. As of December 31, 2012, there were 28 oil producing wells in the Temblador Field. At December 31, 2012, there were 17 oil producing wells and one water injection well in the El Salto field.
Advisors' Opinion:- [By Tess Stynes]
Harvest Natural Resources Inc.(HNR) agreed to sell all the company’s interest in Venezuela for $400 million in cash, as the energy company moves forward with its plans to sell itself.� Shares were up 24% at $4.89 premarket.
- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Monday’s session are Achillion Pharmaceuticals Inc.(ACHN), Active Network Inc.(ACTV) and Harvest Natural Resources Inc.(HNR)
- [By Paul Ausick]
Harvest Natural Resources Inc. (NYSE: HNR) is up 17.3% at $4.62. The independent oil & gas company received an upgrade today based on the belief that company can sell some of its foreign assets.
Hot Trucking Stocks To Invest In Right Now: Allergan Inc. (AGN)
Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment offers a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma therapy, ocular inflammation, infection, allergy, and retinal diseases; Botox for the therapeutic and aesthetic indications; skin care products for acne, psoriasis, and other skin care products; eyelash growth products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products, including the La p-Band System and the Orbera Intragastric Balloon System; and facial aesthetics products. The company also offers Contigen for the treatment of urinary incontinence due to intrinsic sphincter deficiency. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. Allergan, Inc. has strategic research collaboration agreements with ExonHit Therapeutics S.A.; Spectrum Pharmaceuticals, Inc.; and Pieris AG. The company was founded in 1948 and is headquartered in Irvine, California.
Advisors' Opinion:- [By Steven Russolillo]
WATCH FOR: First-Quarter Productivity (8:30 a.m. Eastern Time): seen -1.1%; previously +1.8%. First-Quarter Unit Labor Costs (8:30): seen +2.8%; previously -0.1%. March Consumer Credit (3:00): seen +$16.1 B; previously $16.5B. Allergan(AGN), AOL(AOL), Avis Budget(CAR), CenturyLink, Chesapeake Energy(CHK), CF Industries(CF), Devon Energy(DVN), Duke Energy(DUK), Dynergy, Hertz, Humana, Keurig Green Mountain(GMCR), Lamar Advertising(LAMR), Molson Coors/Miller, Mondelez, Prudential, SolarCity(SCTY), Sotheby's(BID), Tesla Motors(TSLA), Transocean and 21st Century Fox are among companies scheduled to report quarterly results.
- [By Philip Springer]
This was a big week for the global pharmaceutical industry. First, rumors of one deal suggested a possible return to the industry’s old self-destructive ways. But then two other transactions were announced that signaled continuation of a newer trend that’s much healthier for shareholders.
On Monday, it was reported that New York-based Pfizer Inc. (NYSE: PFE) had been in talks to acquire AstraZeneca PLC (NYSE: AZN), headquartered in London, for over $100 billion. The companies apparently broke off the discussions.
If such a transaction were to occur, it would be the latest in a long series of megamergers that characterized the corporate strategies of Pfizer, Swiss drug giant Novartis AG (NYSE: NVS) and others in the 1990s and 2000s. Back then, the aim was to acquire rivals in multibillion-dollar deals that broadened the buyers’ businesses to cover more diseases and new health-care areas.
The catalyst for this buying binge was the so-called patent cliff, in which some of the sector’s biggest drugs faced the loss of patents that protected them from competition, resulting in reduced revenues and earnings.
Since then, however, the patent cliff problem has waned because many of those patent expirations have already occurred. And the bigger, combined companies generally have come up short on development of new blockbuster drugs. Also, excessive diversification has brought weak competitive positions in some niches.
But the current industry trend is for companies to focus more on their core strengths instead of diversifying. Pfizer, Bristol-Myers Squibb (NYSE: BMY), Johnson & Johnson (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT) have made such moves over the last few years in order to focus on what they consider higher-growth prospects.
Tuesday brought more of the same. Novartis and UK-based GlaxoSmithKline (NYSE: GSK) announced more than $20 billion in deals. Novartis is to sell its animal-drugs busi - [By Wallace Witkowski]
Shares of Allergan Inc. (AGN) �and Valeant Pharmaceuticals International Inc. (VRX) �rallied following reports that Pershing Square�� Bill Ackman and Valeant were teaming up to take over Allergan.
- [By Keith Speights]
First, the good news. ACADIA stated on Monday that its partner Allergan (NYSE: AGN ) advanced another new chemical entity from the two companies' collaboration into pre-clinical development. ACADIA's CEO, Dr.��Uli Hacksell, said the molecule has "distinctly different properties from other glaucoma compounds" previously advanced by Allergan. The two companies first partnered on development of new treatments for glaucoma back in 2003.
Hot Trucking Stocks To Invest In Right Now: Vmware Inc.(VMW)
VMware, Inc. provides virtualization and virtualization-based cloud infrastructure solutions in the United States and internationally. The company?s products address planned and unplanned downtime management, system recoverability and reliability, backup and recovery, resource provisioning and management, capacity and performance management, and security issues. Its cloud infrastructure products and technologies include VMware vSphere, which is a data center platform that also enables live migration of actively running virtual machines across servers or storage locations without disruption or downtime; enables availability for all applications against hardware and operating system failures; and enables centralized point of control for cluster-level networking, as well as automatically manages the placement and balancing of a virtual machine across storage resources. The company also offers cloud application platform solutions that help organizations build, run, and manage enterprise applications in public, private, or hybrid clouds optimized for vSphere. In addition, it provides end-user computing solutions, which provide secure access to applications and data from various devices and location, as well as serves the corporate IT departments through managing and connecting end-user assets delivering them as a managed service. The company?s end-user computing solutions also provide the ability to manage software as a service, Windows, Mobile, or enterprise applications, as well as enhance communication and collaboration between end users. Further, it provides a range of professional services, such as consulting, education, and technical account manager services, as well as customer support services. The company sells its products through distributors, resellers, system vendors, and systems integrators. VMware, Inc. was incorporated in 1998 and is headquartered in Palo Alto, California. VMware, Inc. operates as a subsidiary of EMC Corporation.
Advisors' Opinion:- [By Mani]
VMware, Inc.(NYSE:VMW) is expected to announce double-digit growth in earnings when it reports financial results for the third quarter on Oct.21. The company will hold a conference call on the same day at�5 PM�eastern time to discuss the results.
- [By Gregory Ness]
The hybrid cloud is the next major opportunity for disruptive innovation, and companies like Amazon (AMZN), Google (GOOG), Microsoft and VMware (VMW) are well-poised to establish best of breed cloud services. Recent estimates peg investments in cloud infrastructure to now exceed $50B per year.
No comments:
Post a Comment